Transactions
2
Insider / AbbVie Inc.
Quaggin Susan E
Director at AbbVie Inc. · ABBV
Quaggin Susan E, Director at AbbVie Inc., has disclosed 2 transactions in ABBV since May 12, 2026: 0 purchases (0 open-market buys) and 0 sales, worth about $16K at the reported prices. The latest was filed July 2, 2026, 2 days after the trade.
Open-market buys
0
Sales
0
Avg. disclosure lag
3.0d
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source |
|---|---|---|---|---|---|---|---|---|---|
| ABBV | Other A | June 30, 2026 | July 2, 2026 | 2d | 62 | $252 | $16K | derivative | Form 4 ↗ |
| ABBV | Other A | May 8, 2026 | May 12, 2026 | 4d | 1,118 | — | — | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| July 2, 2026 | Form 4 | 0001997505-26-000008 | 1 | published | EDGAR ↗ |
| May 12, 2026 | Form 4 | 0001997505-26-000006 | 1 | published | EDGAR ↗ |
Sources and method
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.